Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMpac Group Plc Regulatory News (MPAC)

Share Price Information for Mpac Group Plc (MPAC)

Share Price is delayed by 15 minutes
Get Live Data
267.50    0.00 (0.00%)
Bid:
265.00
Ask:
270.00
Spread: 5.00 (1.887%)
Market Cap: £80.45m
MPAC Live PriceLast checked at - London Stock Exchange

Intraday Mpac Group Plc Share Chart

Defined Benefit Pension Scheme Update

1 Jul 2025 07:00

RNS Number : 0871P
Mpac Group PLC
01 July 2025
Β 

Β 

1 July 2025

AIM: MPACΒ 

Mpac Group plc

Β 

Trustee of the UK Defined Benefit Pension Scheme completes "buy in" transaction

Β 

Mpac Group plc, a global leader in high-speed packaging and automation solutions, is pleased to announce that the company and the Trustee of the Molins UK Pension Fund (the "Scheme") have agreed a buy in transaction for the Scheme with Aviva Life & Pensions UK Limited ("Aviva"), purchasing a bulk annuity insurance policy for Β£249m, covering all known liabilities required to meet future pensions and delivering greater security to members of the Scheme. This has been achieved without the need for Mpac to make additional contributions, whilst leaving residual assets remaining in the Scheme. The terms of the policy will eliminate the primary investment, inflation and longevity risks that the Scheme is exposed to. The members' benefits are entirely unaffected by this transaction.

Β 

The Scheme will now work towards the transfer of the member's benefits to individual policies with Aviva ("buy out"). This process is expected to take up to two years whilst routine validation checks are performed in conjunction with Aviva and will result in the members' pensions being paid directly by Aviva after the issuance of individual policies. Contributions to escrow will continue until buy out is completed.

Mpac has a defined benefit pension net asset position in relation to the Scheme. This transaction insures the liabilities represented within that net asset position and delivers on Mpac's strategy of de-risking its UK pensions exposure. The transaction will be reflected in our half-year report, to be published in September 2025. The obligation (albeit now fully insured) remains with the Group until the buy-out is completed. The Scheme is anticipated to hold a small surplus of up to Β£5m which will be returned.

Mpac is supportive of the stewardship and de-risking action taken by the Trustee, which creates a positive outcome for the Scheme's members. This transaction eliminates Mpac's exposure to the funding risks associated with our UK defined benefit liabilities which, in turn, strengthens Mpac Group for the benefit of our shareholders.

Will Wilkins, CFO of Mpac, said:Β "The buy in represents a significant step forward in the Group's stated strategy of realising value for shareholders. Not only does it simplify the Group's Balance Sheet, it also eliminates a significant risk to Mpac's future profitability and cash flow."

Β 

For further information, please contact:

Mpac Group plc

Adam Holland, Chief Executive

Will Wilkins, Chief Financial Officer

Tel: +44(0)24 7642 1100

Shore Capital (Nominated Adviser & Broker)

Advisory

Patrick Castle

Sophie Collins

Β 

Broking

Henry Wilcocks

Β 

Tel: +44(0)20 7408 4050

Β 

Panmure LiberumΒ (Joint Broker)

EdwardΒ Mansfield

Will King

Freddie Wooding

Hudson Sandler

Nick Lyon

Nick Moore

Francesca Rosser

Β 

Tel: +44 (0) 20 3100 2000

Β 

Β 

Tel: +44 (0) 20 7796 4133

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
UPDURURRVSUNOUR
Date   Source Headline
26th Jun 202611:46 amRNSTR-1: Notification of major holdings
24th Jun 20269:21 amRNSDirector/PDMR Dealing
19th Jun 20261:58 pmRNSDirector/PDMR Share Dealing
18th Jun 20263:05 pmRNSResult of Annual General Meeting
17th Jun 20262:19 pmRNSTR-1: Notification of major holdings
17th Jun 20262:18 pmRNSPDMR Share Dealing
17th Jun 20268:49 amRNSTR-1: Notification of major holdings
9th Jun 202610:36 amRNSDirector Purchases of Ordinary Shares
8th Jun 20267:00 amRNSTrading Update and Sale of Lambert for up to £20m
15th May 20267:00 amRNSAvailability of 2025 Annual Report & Notice of AGM
24th Apr 20262:00 pmRNSAIM Rule 17 Disclosure
21st Apr 20267:01 amRNSChief Financial Officer Succession
21st Apr 20267:00 amRNSFull Year Results
24th Mar 20267:00 amRNSNotice of Results and Investor Presentation
18th Feb 20264:52 pmRNSChange of Registered Office
2nd Feb 20263:19 pmRNSDirector/PDMR Shareholding
15th Jan 20267:00 amRNSAppointment of Senior Independent Director
15th Jan 20267:00 amRNSFull Year trading update and notice of results
31st Oct 202511:54 amRNSHolding(s) in Company
24th Oct 202510:55 amRNSDirector/PDMR Shareholding
2nd Oct 20254:10 pmRNSDirector/PDMR Shareholding
30th Sep 202512:38 pmRNSHolding(s) in Company
23rd Sep 20257:05 amRNSDirectorate Changes
23rd Sep 20257:00 amRNSHalf Year Results
10th Sep 20252:14 pmRNSNotice of Results and Investor Presentation
31st Jul 20252:26 pmRNSDirectorate Change
8th Jul 202511:39 amRNSHolding(s) in Company
4th Jul 20255:55 pmRNSDirector/PDMR Shareholding
1st Jul 20258:00 amRNS-REquity Development Investor Presentation
1st Jul 20257:00 amRNSDefined Benefit Pension Scheme Update
1st Jul 20257:00 amRNSTrading Update
12th Jun 20255:40 pmRNSResult of AGM
6th Jun 20254:03 pmRNSHolding(s) in Company
23rd May 202511:38 amRNSDirector/PDMR Shareholding
12th May 20257:00 amRNSNotice of AGM
8th May 20254:55 pmRNSDirector/PDMR Shareholding
2nd May 20251:03 pmRNSDirector/PDMR Dealing
29th Apr 20257:00 amRNSFinal Results
7th Apr 20257:00 amRNS-REquity Development Investor Presentation
24th Mar 202510:39 amRNSNotice of Results
25th Feb 20257:00 amRNS-RPension Scheme Valuation Update
23rd Jan 20258:32 amRNSHolding(s) in Company
16th Jan 20257:00 amRNSFull Year Trading update
7th Jan 20253:03 pmRNSHolding(s) in Company
29th Nov 20242:55 pmRNSCompletion of the Acquisition of CSi Palletising
5th Nov 202412:55 pmRNSStandard form for notification of major holdings
5th Nov 20249:39 amRNSStandard form for notification of major holdings
4th Nov 20248:57 amRNSStandard form for notification of major holdings
23rd Oct 20242:55 pmRNSStandard form for notification of major holdings
23rd Oct 202411:25 amRNSStandard form for notification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.